Ledger.Open graph →

SEC Form D · filed December 1, 2015

Velicept Therapeutics, Inc

Offering

$21.1M

Sold

$12.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

MALVERN, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

David Hirsch · Greenwich, CTDirector James Bennethum · Gaylord, MIDirector Scott Morenstein · New York, NYDirector Douglas Gessl · Malvern, PAExec James Walker · Malvern, PAExec · Director Stephen Tullman · Malvern, PADirector John Giordano · Wakefield, MADirector Dave Blundin · Wakefield, MADirector John Shields · Wakefield, MAExec · Director Stanley R. Westreich · Germantown, MDExec Sunil K. Gottipati · Princeton, NJDirector Likai C. Lin · Boston, MADirector Gregory A. Ellis · New York, NYDirector I. R. Garr · Germantown, MDExec Tiffany Freitas · Wakefield, MADirector Paul Abelow · Morganville, NJDirector Dawn A. Cummings · Grand Cayman, Cayman IslandsDirector Amir Haleem · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗